- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/55 - Hydrolases (3)
Patent holdings for IPC class C12N 15/55
Total number of patents in this class: 1329
10-year publication summary
68
|
66
|
59
|
83
|
110
|
86
|
97
|
100
|
88
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3306 |
39 |
Genomatica, Inc. | 512 |
20 |
DSM IP Assets B.V. | 5822 |
18 |
Jiangnan University | 1476 |
18 |
The Regents of the University of California | 19503 |
17 |
Cellectis | 406 |
16 |
University Health Network | 1018 |
15 |
Amano Enzyme Inc. | 360 |
14 |
Codexis, Inc. | 788 |
14 |
President and Fellows of Harvard College | 5911 |
13 |
Pioneer Hi-Bred International, Inc. | 6372 |
10 |
The University of Tokyo | 4055 |
10 |
Sangamo Therapeutics, Inc. | 427 |
10 |
Concordia University | 100 |
9 |
Qingdao Vland Biotech Group Co., Ltd. | 39 |
9 |
Beam Therapeutics Inc. | 209 |
9 |
Shandong Shunfeng Biotechnology Co., Ltd. | 44 |
9 |
Kao Corporation | 4914 |
8 |
Universite Laval | 708 |
8 |
BASF SE | 20403 |
7 |
Other owners | 1056 |